327247
Coalition Building to Address Hepatitis B in Asian American and Pacific Islander Communities
Objective/Purpose: A capacity building program was developed to improve coordination, increase resource sharing/education, and partner engagement. Components include a peer mentoring program, in-person conferences, online trainings, one-on-one technical assistance, and policy advocacy engagement.
Methods: An initial and follow-up survey of the national coalition was conducted to measure member engagement and improved capacity, resources, and education to address HBV in AAPI communities.
Results: Coalition building was successful in increased engagement, resources, and infrastructure development. Members continue to face resource constraints balancing HBV programs with other public health programs; the coalition will have to overcome these barriers and find innovative strategies to sustain member engagement.
Learning Areas:
Advocacy for health and health educationCommunication and informatics
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health or related public policy
Systems thinking models (conceptual and theoretical models), applications related to public health
Learning Objectives:
Explain the disproportionate impact of hepatitis B on Asian American and Pacific Islander immigrant and refugee communities.
Describe national collaborations to address hepatitis B-related health disparities.
Identify key strategies for building and sustaining a public health coalition.
Keyword(s): Hepatitis B, Community-Based Partnership & Collaboration
Qualified on the content I am responsible for because: I have managed programs focused on addressing chronic hepatitis B-related health disparities in immigrant and refugee communities. Among my interests have been the development of national program and policy strategies for reducing racial and ethnic minority disparities in health.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.